FDA.reportPublic FDA data

Atrixtra 2.5 MG per 0.5 ML Prefilled Syringe

RxCUI
861362
RxNorm name
Atrixtra 2.5 MG per 0.5 ML Prefilled Syringe
Display name
Atrixtra 2.5 MG per 0.5 ML Prefilled Syringe
Full name
Atrixtra 2.5 MG per 0.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ArixtraFONDAPARINUX SODIUMMylan Institutional LLCd3b30c68-cf45-4b46-8ba6-72090f7ba01a2024-12-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861362

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d3b30c68-cf45-4b46-8ba6-72090f7ba01aAtrixtra 2.5 MG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe [Arixtra] [SBD] · 0.5 ML Arixtra 5 MG/ML Prefilled Syringe [SY] · Atrixtra 2.5 MG per 0.5 ML Prefilled Syringe [SY]413These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium injection), for subcutaneous use Initial U.S. Approval: 200120241210